Justin Watts, M.D. (IMAGE)
Caption
“We saw really quite remarkable outcomes in a very high-risk MDS population, not only in response rates, but also in blood count improvement, long duration of response and improved overall survival,” said Sylvester physician-scientist Justin Watts, M.D., who led the study.
Credit
Photo by Sylvester Comprehensive Cancer Center
Usage Restrictions
Use with attribution
License
Original content